Profitable Vaccine Distribution In Emerging Markets

Lisa Ganley-Leal and Pauline Mwinzi of Epsilon Therapeutics, Inc. in the U.S. will test the hypothesis that selling vaccines through medicine shops in emerging markets can lead to profits for both vaccine developers and the small business owners. Demonstrating profitability may lead pharmaceutical companies to invest greater resources in vaccine development and distribution and develop local partnerships for profitability strategies.